Skip to Main Content

Paper Details

Bortezomib-based Chemotherapy for Multiple Myeloma Patients Without Comorbid Cardiovascular Disease Shows No Cardiotoxicity.
Clin Lymphoma Myeloma Leuk
2
2018
Author NameAffiliation
Jessica MinnierKnight Cardiovascular Institute, Oregon Health & Science University, OR OHSU-PSU School of Public Health
Maros FerencikKnight Cardiovascular Institute, Oregon Health & Science University
Craig S BrobergKnight Cardiovascular Institute, Oregon Health & Science University
  • 1 - 3

Datasets

Release 1.2